The company historically developed residential and commercial real estate projects in India, but currently operates primarily as a holding entity that earns income from interest on bank deposits and legacy housing loan recoveries.
The company has no competitive advantage, as it has ceased active development projects and relies on passive interest income. Financial metrics like a 4% ROCE and negative cash conversion confirm the lack of any structural business moat.
Earnings are largely left in low-yielding bank fixed deposits rather than being reinvested in growth or returned to shareholders via dividends. The company maintains a high cash balance relative to its operations but generates subpar returns on that capital.
Over the next five years, the company remained a stagnant 'zombie' entity, failing to launch any new development projects while inflation eroded the real value of its idle cash. The persistent disregard for corporate governance eventually led to a total breakdown in regulatory compliance, resulting in delisting or severe SEBI sanctions. As the statutory auditor resigned and tax disputes crystallized into actual liabilities, the market finally realized that the reported accounting profits were merely an illusion of interest income from a shrinking pile of unproductive capital, leading to a permanent collapse in the share price.
RichFakir rates Parshwanath Corporation Ltd's business quality as poor — 24/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Parshwanath Corporation Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Parshwanath Corporation Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Parshwanath Corporation Ltd's fair value is about ₹14 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →